Central Pharmaceuticals Ltd has disclosed its unaudited earnings report for the second Quarter (October’22-Demcember’22).

On Tuesesday (January 31th) The report was released at a meeting of the company’s board of directors.

As per the disclosure, (October’22-Demcember’22) its earnings per share (EPS) has been Tk 0.06 for against one year at the same time earnings per share (EPS) was lost Tk 0.10.

Last 6 months (July’22-Demcember’22) has been lost Tk 0.14 for against one year earnings per share (EPS) was lost Tk 0.18.

31 December 2022 it’s Net Asset Value (NAV)  has been Tk 5.82

nj